THE NUMBER OF ABERRANTLY EXPRESSED CONSTITUENTS OF THE MAMMALIAN TARGET OF RAPAMYCIN PATHWAY: CORRELATION WITH ONCOLOGIC OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA

被引：1
|
作者：
Margulis, Vitaly
Youssef, Ramy
Kapur, Payal
Kabbani, Wareef
Alhalabi, Feras
Arendt, Tyler
Rakheja, Dinesh
Bensalah, Karim
Bagrodia, Adita
Lotan, Yair
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1119
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页码：E435 / E435
页数：1
相关论文
共 50 条
  • [1] NUMBER OF ALTERED BIOMARKERS IN THE MAMMALIAN TARGET OF RAPAMYCIN INDEPENDENTLY CORRELATES WITH ONCOLOGIC OUTCOMES IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA
    Darwish, Oussama
    Youssef, Ramy
    Kapur, Payal
    Bagrodia, Aditya
    Belsante, Michael
    Alhalabi, Feras
    Lotan, Yair
    Margulis, Vitaly
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E525 - E526
  • [2] CLEAR CELL RENAL CELL CARCINOMA: ALTERATIONS IN MAMMALIAN TARGET OF RAPAMYCIN PATHWAY CONSTITUENTS CORRELATE WITH PATHOLOGICAL FEATURES
    Youssef, Ramy
    Darwish, Oussama
    Belsante, Michael
    Bagrodia, Aditya
    Kapur, Payal
    Alhalabi, Feras
    Lotan, Yair
    Margulis, Vitaly
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E400 - E400
  • [3] Cumulative Number of Altered Biomarkers in Mammalian Target of Rapamycin Pathway Is an Independent Predictor of Outcome in Patients With Clear Cell Renal Cell Carcinoma
    Darwish, Oussama M.
    Kapur, Payal
    Youssef, Ramy F.
    Bagrodia, Aditya
    Belsante, Michael
    Alhalabi, Feras
    Sagalowsky, Arthur I.
    Lotan, Yair
    Margulis, Vitaly
    [J]. UROLOGY, 2013, 81 (03) : 581 - 586
  • [4] Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
    Kornakiewicz, Anna
    Solarek, Wojciech
    Bielecka, Zofia F.
    Lian, Fei
    Szczylik, Cezary
    Czarnecka, Anna M.
    [J]. CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (03) : 210 - 218
  • [5] Dysregulation of the Mammalian Target of Rapamycin (mTOR) Pathway in Endometrial Clear Cell Carcinoma
    Weiss, V. L.
    Desouki, M. M.
    Gwin, K.
    Hanley, K. Z.
    Hecht, J. L.
    Jarboe, E. A.
    Liang, S. X.
    Parkash, V.
    Zheng, W.
    Quick, C. M.
    Fadare, O.
    [J]. MODERN PATHOLOGY, 2014, 27 : 311A - 311A
  • [6] Dysregulation of the Mammalian Target of Rapamycin (mTOR) Pathway in Endometrial Clear Cell Carcinoma
    Weiss, V. L.
    Desouki, M. M.
    Gwin, K.
    Hanley, K. Z.
    Hecht, J. L.
    Jarboe, E. A.
    Liang, S. X.
    Parkash, V.
    Zheng, W.
    Quick, C. M.
    Fadare, O.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 311A - 311A
  • [7] Validation of Mammalian Target of Rapamycin Biomarker Panel in Patients with Clear Cell Renal Cell Carcinoma
    Haddad, Ahmed Q.
    Kapur, Payal
    Singla, Nirmish
    Raman, Jay D.
    Then, Matthew T.
    Nuhn, Philipp
    Buchner, Alexander
    Bastian, Patrick
    Seitz, Christian
    Shariat, Shahrokh F.
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    Sagalowsky, Arthur
    Lotan, Yair
    Margulis, Vitaly
    [J]. CANCER, 2015, 121 (01) : 43 - 50
  • [8] Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway
    Youssef, Ramy F.
    Cost, Nicholas G.
    Darwish, Oussama M.
    Margulis, Vitaly
    [J]. ARAB JOURNAL OF UROLOGY, 2012, 10 (02) : 110 - 117
  • [9] Non-Clear Cell Renal Cell Carcinoma: Does the Mammalian Target of Rapamycin Represent a Rational Therapeutic Target?
    Albiges, Laurence
    Molinie, Vincent
    Escudier, Bernard
    [J]. ONCOLOGIST, 2012, 17 (08): : 1051 - 1062
  • [10] Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma
    Vincent Trudeau
    Alessandro Larcher
    Maxine Sun
    Katharina Boehm
    Paolo Dell’Oglio
    José Sosa
    Zhe Tian
    Nicola Fossati
    Alberto Briganti
    Shahrokh F. Shariat
    Pierre I. Karakiewicz
    [J]. World Journal of Urology, 2016, 34 : 1429 - 1436
12345